stage iiia prostate cancer ajcc v8

Showing NaN - NaN of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Adenocarcinoma, Stage II Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8 Trial in Los Angeles (drug,

Not yet recruiting
  • Prostate Adenocarcinoma
  • +3 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Oct 5, 2023

Prostate Adenocarcinoma, Stage IIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage IIC Prostate Cancer AJCC

Recruiting
  • Prostate Adenocarcinoma
  • +7 more
  • High-Dose Rate Brachytherapy
  • Stereotactic Body Radiation Therapy
  • Los Angeles, California
    University of California at Los Angeles / Jonsson Comprehensive
Oct 13, 2022

Prostate Adenocarcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in United States

Recruiting
  • Prostate Adenocarcinoma
  • +6 more
  • Gonadotrophin Releasing Hormone
  • +2 more
  • Gilbert, Arizona
  • +86 more
Sep 27, 2022

Non-Metastatic Prostate Carcinoma, Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8 Trial in Los Angeles (7

Recruiting
  • Non-Metastatic Prostate Carcinoma
  • +9 more
  • 7 Tesla Magnetic Resonance Imaging
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Aug 6, 2022

Information in Patients Undergoing Definitive Radiation Therapy

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +29 more
  • Survey Administration
  • Los Angeles, California
  • +1 more
Aug 5, 2022

Localized Prostate Carcinoma, Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8 Trial in United States (Apalutamide,

Recruiting
  • Localized Prostate Carcinoma
  • +8 more
  • Tucson, Arizona
  • +4 more
Jun 28, 2022

Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage II Prostate Cancer AJCC v8, Stage IIA Prostate

Active, not recruiting
  • Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8
  • +8 more
  • Computed Tomography
  • +3 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Feb 10, 2022